Cyclerion Therapeutics Stock (NASDAQ: CYCN) stock price, news, charts, stock research, profile.
Open | $2.930 |
Close | $2.930 |
Volume / Avg. | 276.000 / 2.910K |
Day Range | 2.930 - 2.930 |
52 Wk Range | 1.750 - 6.750 |
Market Cap | $7.941M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 1.11% |
Days to Cover | 6.96 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cyclerion Therapeutics (NASDAQ: CYCN) through any online brokerage.
Other companies in Cyclerion Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX) and NuCana (NASDAQ:NCNA).
The latest price target for Cyclerion Therapeutics (NASDAQ: CYCN) was reported by Truist Securities on Wednesday, October 20, 2021. The analyst firm set a price target for 14.00 expecting CYCN to rise to within 12 months (a possible 372.97% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $2.96 last updated April 18, 2024 at 8:26 AM EDT.
There are no upcoming dividends for Cyclerion Therapeutics.
Cyclerion Therapeutics’s Q2 earnings are confirmed for Friday, July 26, 2024.
There is no upcoming split for Cyclerion Therapeutics.
Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.